UNSPSC 51372326: Piminodine esylate

This classification denotes an opioid receptor agonist with the molecular formula C23H30N2O2.C2H6O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2C29WCQ951, chemically known as 4-piperidinecarboxylic acid, 4-phenyl-1-(3-(phenylamino)propyl)-, ethyl ester but more generally known as piminodine esylate, which bears US NIH Compound Identifier 21950. Most nations, for tariff and trade purposes, schedule piminodine esylate under HS 29333999 and SITC 51574.

As of Q4 2014, PIMINODINE ESYLATE remains US FDA's Preferred Term for this commodity. Piminodine esylate bears US NLM identifiers UMLS ID C1321936 and NCI Concept Code C80987. SMILES: CCOC(=O)C1(CCN(CC1)CCCNC2CCCCC2)C3CCCCC3.CCS(=O)(=O)O.

UNSPSC 51372326 Piminodine esylate is a Commodity code that in practice captures pharmaceutical and medical supply procurement by state and local health agencies, though recent solicitation activity under this specific code is limited. The code nominally identifies a single pharmaceutical compound, but state and local governments use it to acquire a broader range of emergency medical and public health supplies, including naloxone (opioid reversal agents) and drug deactivation systems for community health initiatives and first-responder programs. Issuing bodies include county health departments and public safety agencies supporting overdose prevention and community health infrastructure.

Geographic activity is concentrated in Florida, where Seminole County posted an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term plus a one-year renewal option and requires E-Verify compliance, drug-free workplace certification, and standard commercial insurance coverage. Beyond this single visible posting, the code shows sparse recent state and local procurement activity; the disconnect between the code's nominal scope (piminodine esylate) and the actual procurement (naloxone and drug deactivation systems) suggests either inconsistent tagging by the issuing body or minimal current use of this specific code designation in state and local contracting.